Vanda Pharmaceuticals, Inc. (VNDA) Misses Q1 Views
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.20 +0.78%
Revenue Growth %: +24.1%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +24.1%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q1 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.14 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
